The growth IBM showed earlier this year is now visibly narrowing to two software lines, while the hardware cycle turns against it. Revenue rose just 1.1% to $17,162 million in the second quarter, down from a 9.5% year-on-year gain in the first quarter (Q1 derived from the filing's six-month revenue of $33,079 million against $31,519 million) — and the deceleration lands precisely as the company laps its z17 mainframe, announced April 8, 2025 and generally available June 18, 2025. Net income fell to $2,165 million from $2,194 million, breaking a second-quarter earnings line that had compounded at 11.0% a year since 2023, even though IBM closed the $11.6 billion Confluent acquisition on March 17 and consolidated it for the full quarter. The offsetting story is cash: first-half operating cash flow of $7,766 million was up $1,695 million from $6,071 million a year earlier, and the balance sheet now carries $88.6 billion of goodwill and intangibles against $34.5 billion of equity. All figures are drawn from IBM's Q2 2026 Form 10-Q unless otherwise noted.
1. Consolidated Balance Sheet
1-1. Major asset movements
| Item | Dec 31, 2025 ($M) | Jun 30, 2026 ($M) | Change % |
|---|---|---|---|
| Cash and cash equivalents | 13,587 | 7,172 | −47.2 |
| Marketable securities | 830 | 960 | +15.7 |
| Trade receivables (net) | 8,112 | 6,044 | −25.5 |
| Total inventory | 1,220 | 1,746 | +43.1 |
| Property, plant and equipment (net) | 5,899 | 5,736 | −2.8 |
| Financing receivables (short + long) | 16,183 | 13,782 | −14.8 |
| Goodwill | 67,717 | 74,599 | +10.2 |
| Intangible assets (net) | 11,391 | 13,955 | +22.5 |
| Total assets | 151,880 | 152,099 | +0.1 |
Total assets barely moved, but the composition changed materially. Cash fell $6.4 billion while goodwill plus intangibles rose $9.4 billion net of amortization. Confluent accounts for almost all of it: the purchase price allocation booked $7,238 million of goodwill and $3,834 million of acquired intangibles (client relationships $2,122 million, completed technology $1,590 million, trademarks $122 million), of which $7,149 million of goodwill went to the Software segment and $89 million to Consulting. Goodwill plus intangibles now equal 58.2% of total assets and 2.6 times total equity; tangible book value is negative $54.0 billion. That is a structural feature of IBM's model rather than a new development, but the Confluent deal, which closed in the first quarter, deepened it.
Two line items deserve attention. Trade receivables fell 25.5% — partly the normal drawdown from a seasonally heavy fourth quarter, and partly the collapse in sales-type lease originations (selling price of $273 million in Q2 2026 versus $877 million a year earlier, the direct footprint of the z17 launch quarter dropping out of the comparison). Inventory moved the other way, up 43.1%, driven by work in process and raw materials rising to $1,425 million from $990 million, even as Infrastructure revenue fell 7.4%. The filing does not explain the build. It is consistent with staging for a next-generation hardware transition — IBM signed a definitive agreement on July 22, 2026 to acquire a business that will be integrated into the Infrastructure segment on closing, expected in the second half of 2026 subject to regulatory approval; the filing does not name the target — but a demand shortfall would look identical on this line. It is a number to re-check next quarter.
1-2. Debt structure
Total financial debt was essentially flat at $61,987 million (short-term $5,775 million plus long-term $56,212 million) versus $61,260 million at year-end: $7,437 million of new issuance was almost entirely offset by $7,141 million of repayments, leaving net new borrowing of just $296 million. Because cash fell so sharply, net debt rose to $53,810 million from $46,789 million, a $7.0 billion increase. That is less than the $10,480 million of cash actually paid for acquisitions net of cash acquired, and the bridge is operating cash flow, not financing: the $7,766 million generated in the half covered most of the gap before $3,166 million of dividends and $774 million of capex and capitalized software took it back out. Marketable securities did not fund the deal — that balance rose to $960 million from $830 million. Debt-to-equity improved to 179.5% from 187.1%, but the driver was share issuance rather than earnings: paid-in capital added $1,282 million of the $1,801 million equity increase, against $562 million from other comprehensive income and only $289 million of retained earnings.
The maturity ladder is comfortable: pre-swap contractual maturities are $437 million for the rest of 2026, $6,713 million in 2027 and $6,001 million in 2028 — only 20.8% of the $63,076 million total falls due through 2028, with $39,894 million pushed beyond 2030. The refinancing cost, however, is visible. The February 3, 2026 issuance priced U.S. dollar tranches at 4.0–5.8% and euro tranches at 3.0–3.85%, against legacy euro paper still carrying 0.7% (2032) and 1.2% (2028) coupons. Net interest expense outside the Financing segment rose to $413 million from $343 million in the quarter, while interest income inside other (income) and expense halved to $86 million from $172 million as the cash pile was spent. The $10 billion revolving credit facility, extended on June 22, 2026 to 2029 and 2031, was fully undrawn, and IBM states it is in compliance with its covenants, including the credit-facility requirement that its consolidated net interest expense ratio not fall below 2.20 to 1.0.
Operating liabilities were flat to lower: accounts payable $4,395 million (−7.6%), compensation and benefits $3,364 million (−18.2%), and total deferred income of $20,432 million versus $20,372 million. That last figure is worth noting — deferred income was essentially unchanged half-on-half despite a full quarter of an acquired subscription business, though purchase accounting typically writes down acquired deferred revenue and muddies the comparison.
1-3. Capital structure
Paid-in capital rose to $64,600 million from $63,318 million, while retained earnings advanced only $289 million against six-month net income of $3,381 million (dividends declared of roughly $3,092 million; cash dividends paid were $3,166 million, or 93.6% of first-half earnings). Treasury stock increased by just $329 million, all of it from employee-plan settlements; there was no open-market repurchase. Accumulated other comprehensive loss narrowed to $15,151 million from $15,713 million, driven by a $309 million improvement in retirement-related items and $285 million on cash flow hedges. Total equity of $34,541 million against $152,099 million of assets means the company is funded overwhelmingly by debt and deferred income, which is the shape you would expect but leaves limited absorption capacity for a goodwill impairment.
2. Consolidated Income Statement
2-1. Headline results
| Item | Q2 2025 ($M) | Q2 2026 ($M) | Change % |
|---|---|---|---|
| Revenue | 16,977 | 17,162 | +1.1 |
| Total reportable segment profit | 4,003 | 4,092 | +2.2 |
| Segment profit margin (%) | 23.5 | 23.9 | — |
| Pre-tax income (continuing ops) | 2,597 | 2,479 | −4.5 |
| Pre-tax margin (%) | 15.3 | 14.4 | — |
| Net income | 2,194 | 2,165 | −1.3 |
| Net margin (%) | 12.9 | 12.6 | — |
| Diluted EPS ($) | 2.31 | 2.27 | −1.7 |
For six months, revenue was $33,079 million (+4.9%), segment profit $7,392 million (+9.9%) and diluted EPS $3.55 (+3.5%). Over a longer window the second-quarter revenue line runs $15,475 million (2023), $15,770 million (2024), $16,977 million (2025) and $17,162 million (2026) — a 3.5% three-year compound rate (2023 and 2024 figures per IBM's second-quarter 10-Q filings for those years), with second-quarter net income compounding at 11.0% over the same span (2023 base year per those same filings). This quarter broke that pattern on the earnings line.
Operating leverage at the segment level is intact and strong: reportable segment revenue up 0.6% ($17,110 million from $17,009 million) produced segment profit up 2.2%, a ratio of about 3.7x, versus roughly 2.1x over six months. Everything that went wrong sat below segment profit. Amortization of acquired intangibles rose to $664 million from $549 million, acquisition-related charges to $52 million from $26 million, non-operating retirement costs to $96 million from $25 million, stock-based compensation to $483 million from $424 million, and net interest to $413 million from $343 million. Stripping out the three acquisition and retirement items — that is, adding back $664 million, $52 million and $96 million in 2026 versus $549 million, $26 million and $25 million in 2025 — normalized pre-tax income was $3,291 million versus $3,197 million, up 2.9%, with the margin improving to 19.2% from 18.8%. The underlying business held its ground; deal accounting did the damage.
The effective tax rate fell to 12.6% from 15.6%. Had the prior-year rate applied, diluted EPS would have been roughly $2.19 rather than $2.27 — meaning the reported 1.7% EPS decline would have been closer to 5%. A rising diluted share count (952.7 million for six months versus 946.7 million, up 0.6%) is a second small headwind, and one that will persist while IBM issues stock for acquisitions and does not repurchase; the Confluent deal alone added 3.0 million assumed stock awards with a fair value of $665 million.
2-2. Where the margin came from
IBM does not present a gross margin in this filing, but the segment tables allow a proxy. Segment cost — the direct delivery and product cost — rose to 39.98% of segment revenue from 39.55%, a 43 basis point deterioration. "Other expenses and income," which is essentially SG&A plus R&D and behaves as a fixed cost base, fell to 36.10% from 36.91%, an 81 basis point improvement, and declined 1.6% in absolute dollars while revenue grew. The entire margin expansion came from operating cost discipline, not from a better cost of revenue.
| Segment (Q2) | Revenue 2026 ($M) | Rev. Δ% | Profit 2026 ($M) | Margin 2026 | Margin 2025 |
|---|---|---|---|---|---|
| Software | 7,761 | +5.1 | 2,502 | 32.2% | 31.1% |
| Consulting | 5,327 | +0.2 | 647 | 12.1% | 10.6% |
| Infrastructure | 3,835 | −7.4 | 835 | 21.8% | 23.3% |
| Financing | 186 | +12.2 | 108 | 58.0% | 107.9% |
| Total segments | 17,110 | +0.6 | 4,092 | 23.9% | 23.5% |
Software is now 45.2% of revenue but 61.1% of segment profit, up from 43.5% and 57.4%. Its direct cost ratio worsened to 17.4% from 16.1% — Confluent's cost base and purchase accounting arriving — yet segment profit margin still rose 110 basis points because SG&A and R&D were held at $3,910 million versus $3,900 million while revenue grew 5.1%. Consulting is the cleaner story and the more fragile one: revenue was flat at +0.2%, and the 150 basis point margin gain came entirely from cutting delivery cost to 71.1% of revenue from 72.5%. That is a lever with a finite number of pulls. Infrastructure shows the cycle in reverse — cost stayed at $1,596 million on 7.4% less revenue, pushing the cost ratio to 41.6% from 38.5%, and only an 11% cut in Infrastructure SG&A and R&D (to roughly $1,404 million from $1,580 million) limited the margin loss to 150 basis points. Financing's margin above 100% in the prior year reflects intercompany financing income tied to the z17 launch, which is why its normalization to 58.0% should be read as a cycle artifact rather than a deterioration.
Within Software, the product split is the sharpest evidence of the two forces at work: Hybrid Cloud $1,998 million (+11.2%), Data $1,782 million (+18.9%), Automation $1,951 million (+3.6%), and Transaction Processing $2,030 million (−8.1%). Data's jump coincides with the first full quarter of Confluent, and the filing provides no pro forma disclosure to separate organic from acquired growth. Transaction Processing is mainframe-attached software and fell for the same reason the hardware did.
3. Consolidated Cash Flow
| Item (six months) | 2025 ($M) | 2026 ($M) | Change |
|---|---|---|---|
| Operating cash flow | 6,071 | 7,766 | +$1,695M (+27.9%) |
| Investing cash flow | (11,281) | (10,970) | +$311M |
| Financing cash flow | 2,589 | (3,008) | −$5,597M |
| Net change in cash and restricted cash | (2,134) | (6,423) | −$4,289M |
| Ending cash and restricted cash | 12,026 | 7,217 | −40.0% |
Free cash flow, defined here as operating cash flow less payments for property, plant and equipment ($461 million) and investment in software ($313 million), was $6,992 million against $5,303 million, up 31.9%, lifting the free cash flow margin to 21.1% from 16.8%. IBM's own free cash flow definition also adjusts for financing receivables, so this figure will not tie exactly to the company's reported number.
The quality of that gain deserves scrutiny. Six-month net income rose only 4.1%, to $3,381 million from $3,249 million, so almost none of the $1,695 million cash-flow improvement came from earnings. It came from non-cash charges — amortization of acquired intangibles stepped up with Confluent — and from working capital, with trade receivables down $2,068 million over the half. Receivable liquidation is a one-time source. If Infrastructure revenue stabilizes and receivables rebuild, that tailwind reverses.
Investing outflows were roughly unchanged at $10,970 million, but the composition tells the story: $10,480 million of it was acquisitions net of cash acquired, against $7,845 million a year earlier. Spending on the existing business is small by comparison — $461 million of PP&E and $313 million of software over six months, on a $152 billion balance sheet. IBM is buying growth rather than building it.
The financing line swung by $5.6 billion, from $2,589 million provided to $3,008 million used. That is not a change in shareholder policy — dividends were $3,166 million versus $3,112 million, and there were still no open-market buybacks — but a change in funding mix. Net new borrowing was $296 million this half against $5,820 million a year earlier. In 2025 IBM funded $7,845 million of acquisitions largely with debt; in 2026 it funded Confluent out of the cash pile, and the pile is now gone.
That is the number to watch. Cash and equivalents of $7,172 million now sit against $5,775 million of short-term debt — a cushion of $1.4 billion where there was $7.2 billion at year-end. The undrawn $10 billion revolver and $7,766 million of half-year operating cash flow make this a liquidity inconvenience rather than a liquidity problem. But the optionality is spent. The next deal, including the unnamed Infrastructure target signed on July 22, gets funded with debt priced at 4.0–5.8% on the dollar tranches, not with a zero-cost balance sheet, and it will land on a company already carrying $88.6 billion of goodwill and intangibles against $34.5 billion of equity.
The quarter, stripped down: the underlying business grew normalized pre-tax income 2.9% and widened that margin by about 35 basis points; the mainframe cycle took 7.4% off Infrastructure and unwound the Financing segment's prior-year windfall; Confluent bought a Data line growing 18.9% and paid for it in amortization, cash and a slightly larger share count. Nothing here is broken. But 1.1% is the honest top-line number, and three items — the unexplained Infrastructure inventory build, the flat deferred income line, and the receivables that will eventually stop falling — will decide over the next two quarters whether 1.1% was the trough of a hardware transition or the run rate.